ORCHESTRA BIOMED HOLDINGS IN (OBIO) Stock Income Statement
NASDAQ:OBIO - Nasdaq - US68572M1062 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.89M | 2.64M | 2.76M | 3.53M | -780.00K | |||
| Cost Of Goods | 214.00K | 204.00K | 186.00K | 210.00K | 200.00K | |||
| Gross Profit | 2.67M | 2.43M | 2.57M | 3.32M | -980.00K | |||
| Operating Expenses | 71.47M | 66.73M | 54.08M | 35.98M | 20.82M | |||
| Research and Development | 47.17M | 42.80M | 33.82M | 21.95M | 12.89M | |||
| Selling, General, and Administrative Expenses | 24.30M | 23.93M | 20.26M | 14.03M | 7.93M | |||
| Operating Income | -68.80M | -64.30M | -51.51M | -32.66M | -21.80M | |||
| Interest Income/Expense | 2.48M | 3.29M | 3.54M | -270.00K | -1.22M | |||
| Other Income/Expense | 0.00 | -11.00K | N/A | N/A | N/A | |||
| Non Recurring Items | N/A | N/A | -1.15M | -680.00K | 0.00 | |||
| Income Before Taxes | -66.32M | -61.02M | -49.12M | -33.61M | -23.01M | |||
| Net Income | -66.32M | -61.02M | -49.12M | -35.62M | -23.01M | |||
| EBITDA | -68.48M | -63.99M | -51.22M | -32.44M | -21.62M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.77 | -1.66 | -1.48 | -1.13 | -0.73 | |||
| Non GAAP EPS | -1.77 | -1.66 | -1.50 | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 92.58% | 92.27% | 93.26% | 94.05% | 125.64% | |||
| Profit Margin | -2297.85% | -2313.27% | -1779.71% | -1009.07% | 2950.00% | |||
| Operating Profit Margin | -2383.89% | -2437.49% | -1866.16% | -925.21% | 2794.87% | |||
All data in USD